The unmasking of <it<Pneumocystis jiroveci </it<pneumonia during reversal of immunosuppression: case reports and literature review
<p<Abstract</p< <p<Background</p< <p<Pneumocystis jiroveci pneumonia (PCP) is an important opportunistic infection among immunosuppressed patients, especially in those infected with human immunodeficiency virus (HIV). The clinical presentation of PCP in immunosuppressed patients have been well-reported in the literature. However, the clinical importance of PCP manifesting in the setting of an immunorestitution disease (IRD), defined as an acute symptomatic or paradoxical deterioration of a (presumably) preexisting infection, which is temporally related to the recovery of the immune system and is due to immunopathological damage associated with the reversal of immunosuppressive processes, has received relatively little attention until recently.</p< <p<Case presentation</p< <p<We aim to better define this unique clinical syndrome by reporting two cases of PCP manifesting acutely with respiratory failure during reversal of immunosuppression in non-HIV infected patients, and reviewed the relevant literature. We searched our databases for PCP cases manifesting in the context of IRD according to our predefined case definition, and reviewed the case notes retrospectively. A comprehensive search was performed using the Medline database of the National Library of Medicine for similar cases reported previously in the English literature in October 2003. A total of 28 non-HIV (excluding our present case) and 13 HIV-positive patients with PCP manifesting as immunorestitution disease (IRD) have been reported previously in the literature. During immunorestitution, a consistent rise in the median CD4 lymphocyte count (28/μL to 125/μL), with a concomitant fall in the median HIV viral load (5.5 log<sub<10 </sub<copies/ml to 3.1 log<sub<10 </sub<copies/ml) was observed in HIV-positive patients who developed PCP. A similar upsurge in peripheral lymphocyte count was observed in our patients preceding the development of PCP, as well as in other non-HIV immunosuppressed patients reported in the literature.</p< <p<Conclusions</p< <p<PCP manifesting as IRD may be more common than is generally appreciated. Serial monitoring of total lymphocyte or CD4 count could serve as a useful adjunct to facilitate the early diagnosis and pre-emptive treatment of this condition in a wide range of immunosuppressed hosts, especially in the presence of new pulmonary symptoms and/or radiographic abnormalities compatible with the diagnosis.</p<.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2004 |
|---|---|
| Erschienen: |
2004 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
BMC Infectious Diseases - 4(2004), 1, p 57 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hui David S [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1186/1471-2334-4-57 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ063651866 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ063651866 | ||
| 003 | DE-627 | ||
| 005 | 20230501205704.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2334-4-57 |2 doi | |
| 035 | |a (DE-627)DOAJ063651866 | ||
| 035 | |a (DE-599)DOAJd9d64f7a4d114eb68ad8b28f88e00329 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Hui David S |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The unmasking of <it<Pneumocystis jiroveci </it<pneumonia during reversal of immunosuppression: case reports and literature review |
| 264 | 1 | |c 2004 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a <p<Abstract</p< <p<Background</p< <p<Pneumocystis jiroveci pneumonia (PCP) is an important opportunistic infection among immunosuppressed patients, especially in those infected with human immunodeficiency virus (HIV). The clinical presentation of PCP in immunosuppressed patients have been well-reported in the literature. However, the clinical importance of PCP manifesting in the setting of an immunorestitution disease (IRD), defined as an acute symptomatic or paradoxical deterioration of a (presumably) preexisting infection, which is temporally related to the recovery of the immune system and is due to immunopathological damage associated with the reversal of immunosuppressive processes, has received relatively little attention until recently.</p< <p<Case presentation</p< <p<We aim to better define this unique clinical syndrome by reporting two cases of PCP manifesting acutely with respiratory failure during reversal of immunosuppression in non-HIV infected patients, and reviewed the relevant literature. We searched our databases for PCP cases manifesting in the context of IRD according to our predefined case definition, and reviewed the case notes retrospectively. A comprehensive search was performed using the Medline database of the National Library of Medicine for similar cases reported previously in the English literature in October 2003. A total of 28 non-HIV (excluding our present case) and 13 HIV-positive patients with PCP manifesting as immunorestitution disease (IRD) have been reported previously in the literature. During immunorestitution, a consistent rise in the median CD4 lymphocyte count (28/μL to 125/μL), with a concomitant fall in the median HIV viral load (5.5 log<sub<10 </sub<copies/ml to 3.1 log<sub<10 </sub<copies/ml) was observed in HIV-positive patients who developed PCP. A similar upsurge in peripheral lymphocyte count was observed in our patients preceding the development of PCP, as well as in other non-HIV immunosuppressed patients reported in the literature.</p< <p<Conclusions</p< <p<PCP manifesting as IRD may be more common than is generally appreciated. Serial monitoring of total lymphocyte or CD4 count could serve as a useful adjunct to facilitate the early diagnosis and pre-emptive treatment of this condition in a wide range of immunosuppressed hosts, especially in the presence of new pulmonary symptoms and/or radiographic abnormalities compatible with the diagnosis.</p< | ||
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Lee Rodney A |e verfasserin |4 aut | |
| 700 | 0 | |a Hung Ivan FN |e verfasserin |4 aut | |
| 700 | 0 | |a Tang Bone SF |e verfasserin |4 aut | |
| 700 | 0 | |a Cheng Vincent CC |e verfasserin |4 aut | |
| 700 | 0 | |a Wu Alan KL |e verfasserin |4 aut | |
| 700 | 0 | |a Yuen Kwok Y |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Infectious Diseases |d BMC, 2003 |g 4(2004), 1, p 57 |w (DE-627)DOAJ000056693 |x 14712334 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2004 |g number:1, p 57 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2334-4-57 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d9d64f7a4d114eb68ad8b28f88e00329 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.biomedcentral.com/1471-2334/4/57 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-2334 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2004 |e 1, p 57 | ||